Explore more publications!

America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on February 5, 2026

Level 5 Capital Partners Completes Acquisition of 180-Unit Apartment Community in Mansfield, Ohio
Juego Gratuito de Autoconocimiento Expande Coaching a 750 Millones de Hispanohablantes y Lusohablantes
ECER Inc – Forest Hills Launches Dedicated Electronics Recycling Pickup Service for Long Island Businesses
Hantec Markets Limited Named Official Partner of UFC Across Asia Pacific in Multiyear Agreement
Colombia’s Senate urged to pass bill on female genital mutilation before legislative deadline
Industry Veteran Taylor Jones’ Wishbone Advisory Launches New eCom & B2B Scale-Up Engines for the Home Products Industry
El Senado de Colombia tiene hasta junio para aprobar ley contra la mutilación genital femenina
CHZ Lighting Beats Global Competitors to Illuminate Historic Spanish Stadium with Future-Ready LED Technology
Emotive Year-in-Review: Dealers ‘Run on One Connected View’ as Modern ERP Momentum Accelerates
Hollywood Veteran to Join Congressional Candidate for 'The Dallas Summit: Film & Streaming as an Economic Engine'
Bitget Wallet Expands Into B2B With Trading Infrastructure API
Royalton Fan Fest Launches for 2026 With a Global Soccer Celebration and Exclusive Packages
Royalton Fan Fest se lanza en 2026 con una celebración global del fútbol y paquetes exclusivos
Erdene Announces Closing of $25 Million Bought Deal Private Placement
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Radix to Showcase 'Vision to Value' Strategies as Silver Sponsor of ARC Industry Leadership Forum 2026
Bitget Posts 45.5% Growth Rate Among Top Crypto Exchanges in 2025
ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions